The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Meta‐analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability
Open accessAbstract
Introduction: Loss of synapses best correlates to cognitive deficits in Alzheimer's disease (AD) in which oligomeric neurotoxic species of amyloid‐β appears to contribute synaptic pathology. Although a number of clinical pathologic studies have been performed with limited sample size, there are no systematic studies encompassing large samples. Therefore, we performed a meta‐analysis study. Methods: We identified 417 publications reporting postmortem synapse and synaptic marker loss from AD patients. Two meta‐analyses were performed using a single database of subselected publications and calculating the standard mean differences. Results: Meta‐analysis confirmed synaptic loss in selected brain regions is an early event in AD pathogenesis. The second meta‐analysis of 57 synaptic markers revealed that presynaptic makers were affected more than postsynaptic markers. Discussion: The present meta‐analysis study showed a consistent synaptic loss across brain regions and that molecular machinery including endosomal pathways, vesicular assembly mechanisms, glutamate receptors, and axonal transport are often affected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Self-citationDiagnostic and Statistical Manual of Mental Disorders
Raber, G., & Spokas, M. (2025) · The Sage Encyclopedia of Mood and Anxiety Disorders · doi:10.4135/9781071886229.n145 · Cited by 2,764
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Advanced methods in meta‐analysis: multivariate approach and meta‐regression
van Houwelingen, H. C., Arends, L. R., & Stijnen, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1040 · Cited by 1,580
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 1×
“Specifically, a significant reduction in synapse numbers in the CA1 region of the hippocampus and the inferior temporal cortex has been demonstrated by electron microscopy [16,17].”
BackgroundSynaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., & Mufson, E. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260698.46517.8f · Cited by 824
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., Wisniewski, T., Gunther, E. C., & Strittmatter, S. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3178 · Cited by 662
Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S.-I., Dziewczapolski, G., Nakamura, T., Cao, G., Pratt, A. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306832110 · Cited by 600
Self-citationSZE, C.-I., TRONCOSO, J. C., KAWAS, C., MOUTION, P., PRICE, D. L., & MARTIN, L. J. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00011 · Cited by 562
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468
Quantitative assessment of cortical synaptic density in Alzheimer's disease
Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446
Synapses and Alzheimer's Disease
Sheng, M., Sabatini, B. L., & Sudhof, T. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005777 · Cited by 436
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
Cissé, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., Orr, A., Lotz, G., Kim, D. H., Hamto, P., et al. (2011) · Nature · doi:10.1038/nature09635 · Cited by 433
Synaptic loss in Alzheimer's disease and other dementias
Hamos, J. E., DeGennaro, L. J., & Drachman, D. A. (1989) · Neurology · doi:10.1212/wnl.39.3.355 · Cited by 432
Quantitative synaptic alterations in the human neocortex during normal aging
Masliah, E., Mallory, M., Hansen, L., DeTeresa, R., & Terry, R. D. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.192 · Cited by 408
Self-citationDifferential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
Reddy, P. H., Mani, G., Park, B. S., Jacques, J., Murdoch, G., Whetsell, W., Kaye, J., & Manczak, M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7203 · Cited by 372
Synaptic and neuritic alterations during the progression of Alzheimer's disease
Masliah, E., Mallory, M., Hansen, L., Richard, D., Alford, M., & Terry, R. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90121-x · Cited by 370
Self-citationCortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.
Masliah, E., Terry, R. D., Alford, M. F., DeTeresa, R. M., & Hansen, L. A. (1991) · PubMed · Cited by 328
Self-citationSynaptic Loss in the Inferior Temporal Gyrus in Mild Cognitive Impairment and Alzheimer's Disease
Scheff, S. W., Price, D. A., Schmitt, F. A., Scheff, M. A., & Mufson, E. J. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101782 · Cited by 300
Lue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299
Masliah, E., Terry, R. D., Alford, M., & DeTeresa, R. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.6.2110586 · Cited by 267
Self-citationSynapse loss in the temporal lobe in Alzheimer's disease
Scheff, S. W., & Price, D. A. (1993) · Annals of Neurology · doi:10.1002/ana.410330209 · Cited by 263
Lue, L.-F., Brachova, L., Civin, H. W., & Rogers, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199655100-00008 · Cited by 246
Mufson, E. J., Ma, S. Y., Cochran, E. J., Bennett, D. A., Beckett, L., Jaffar, S., Saragovi, H. U., & Kordower, J. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001106)427:1<19::aid-cne2>3.0.co;2-a · Cited by 243
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Overk, C. R., & Masliah, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.015 · Cited by 242
Self-citationEarly Diagnosis of Alzheimers Disease: Is MCI Too Late?
Petersen, R. (2009) · Current Alzheimer Research · doi:10.2174/156720509788929237 · Cited by 240
Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease
Flynn, D. D., Ferrari‐DiLeo, G., Mash, D. C., & Levey, A. I. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041888.x · Cited by 234
Counts, S. E., Nadeem, M., Lad, S. P., Wuu, J., & Mufson, E. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00007 · Cited by 215
Pham, E., Crews, L., Ubhi, K., Hansen, L., Adame, A., Cartier, A., Salmon, D., Galasko, D., Michael, S., Savas, J. N., et al. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07719.x · Cited by 206
Self-citationDysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors
Mota, S. I., Ferreira, I. L., & Rego, A. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.013 · Cited by 206
Blennow, K., Bogdanovic, N., Alafuzoff, I., Ekman, R., & Davidsson, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01273157 · Cited by 206
Decreased thioredoxin and increased thioredoxin reductase levels in alzheimer’s disease brain
Lovell, M. A., Xie, C., Gabbita, S. P., & Markesbery, W. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00258-0 · Cited by 202
Fu, A. K. Y., Hung, K.-W., Huang, H., Gu, S., Shen, Y., Cheng, E. Y. L., Ip, F. C. F., Huang, X., Fu, W.-Y., & Ip, N. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405803111 · Cited by 201
Hof, P. R., & Morrison, J. H. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90096-u · Cited by 197
Kirvell, S. L., Esiri, M., & Francis, P. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03935.x · Cited by 187
Shim, K. S., & Lubec, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00210-0 · Cited by 186
Heinonen, O., Soininen, H., Sorvari, H., Kosunen, O., Palja¨rvi, L., Koivisto, E., & Riekkinen, P. J. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00422-2 · Cited by 186
Masliah, E., Ellisman, M., Carragher, B., Mallory, M., Young, S., Hansen, L., Deteresa, R., & Terry, R. D. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199207000-00003 · Cited by 183
Self-citationReduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease
Counts, S. E., Nadeem, M., Wuu, J., Ginsberg, S. D., Saragovi, H. U., & Mufson, E. J. (2004) · Annals of Neurology · doi:10.1002/ana.20233 · Cited by 183
Neurochemical Dissection of Synaptic Pathology in Alzheimer's Disease
Davidsson, P., & Blennow, K. (1998) · International Psychogeriatrics · doi:10.1017/s1041610298005110 · Cited by 182
Kashani, A., Lepicard, È., Poirel, O., Videau, C., David, J. P., Fallet-Bianco, C., Simon, A., Delacourte, A., Giros, B., Epelbaum, J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.010 · Cited by 175
Sultana, R., Banks, W. A., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22227 · Cited by 170
SAMUEL, W., ALFORD, M., HOFSTETTER, C. R., & HANSEN, L. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199705000-00006 · Cited by 167
Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer’s disease brains
Sze, C.-I., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., & Martin, L. J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00285-9 · Cited by 161
Lassmann, H., Weiler, R., Fischer, P., Bancher, C., Jellinger, K., Floor, E., Danielczyk, W., Seitelberger, F., & Winkler, H. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90003-k · Cited by 160
Liu, X., Erikson, C., & Brun, A. E. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106867 · Cited by 151
Sze, C., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., & Martin, L. J. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00467-6 · Cited by 149
de Ruiter, J. P., & Uylings, H. B. M. (1987) · Brain Research · doi:10.1016/0006-8993(87)90028-x · Cited by 141
Ginsberg, S. D., Mufson, E. J., Alldred, M. J., Counts, S., Wuu, J., Nixon, R. A., & Che, S. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.05.012 · Cited by 140
Altered synapses and gliotransmission in Alzheimer's disease and AD model mice
Mitew, S., Kirkcaldie, M. T. K., Dickson, T. C., & Vickers, J. C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.010 · Cited by 138
Alzheimer's disease and aging: Effects on perforant pathway perikarya and synapses
Lippa, C. F., Hamos, J. E., Pulaski-Salo, D., DeGennaro, L. J., & Drachman, D. A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90115-e · Cited by 135
Ginsberg, S. D., Mufson, E. J., Counts, S., Wuu, J., Alldred, M. J., Nixon, R. A., & Che, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101080 · Cited by 135
Synapses and Dendritic Spines as Pathogenic Targets in Alzheimer’s Disease
Yu, W., & Lu, B. (2012) · Neural Plasticity · doi:10.1155/2012/247150 · Cited by 134
Bertoni–Freddari, C., Fattoretti, P., Casoli, T., Meier-Ruge, W. A., & ULRICH, J. (1990) · Brain Research · doi:10.1016/0006-8993(90)91009-6 · Cited by 132
The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease
Tiraboschi, P., Hansen, L. A., Alford, M. F., Masliah, E., Thal, L. J., & Corey‐Bloom, J. (2000) · Neurology · doi:10.1212/wnl.55.9.1278 · Cited by 130
Self-citationParvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer’s diseased brain
Brady, D. R., & Mufson, E. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00068-7 · Cited by 125
Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease
Arnold, S. E., Louneva, N., Cao, K., Wang, L.-S., Han, L.-Y., Wolk, D. A., Negash, S., Leurgans, S. E., Schneider, J. A., Buchman, A. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.004 · Cited by 123
Is synaptic loss a unique hallmark of Alzheimer’s disease?
Scheff, S. W., Neltner, J. H., & Nelson, P. T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.028 · Cited by 118
Shinohara, M., Fujioka, S., Murray, M. E., Wojtas, A., Baker, M., Rovelet-Lecrux, A., Rademakers, R., Das, P., Parisi, J. E., Graff-Radford, N. R., et al. (2014) · Brain · doi:10.1093/brain/awu046 · Cited by 115
Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer’s disease
Riascos, D., de Leon, D., Baker‐Nigh, A., Nicholas, A., Yukhananov, R. Y., Bu, J., Wu, C., & Geula, C. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0865-4 · Cited by 115
Premorbid effects of APOE on synaptic proteins in human temporal neocortex
Love, S., Siew, L. K., Dawbarn, D., Wilcock, G. K., Ben‐Shlomo, Y., & Allen, S. J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.008 · Cited by 115
Zhan, S., Beyreuther, K. T., & Schmitt, H. P. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107299 · Cited by 111
Leuba, G., Savioz, A., Vernay, A., Carnal, B., Kraftsik, R., Tardif, É., Riederer, I. M., & Riederer, B. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15112 · Cited by 106
Wakabayashi, K., Honer, W. G., & Masliah, E. (1994) · Brain Research · doi:10.1016/0006-8993(94)91709-4 · Cited by 102
Self-citationBrun, A. E., Liu, X., & Erikson, C. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0021 · Cited by 99
Hippocampal Drebrin Loss in Mild Cognitive Impairment
Counts, S., He, B., Nadeem, M., Wuu, J., Scheff, S. W., & Mufson, E. J. (2012) · Neurodegenerative Diseases · doi:10.1159/000333122 · Cited by 99
Lovell, M. A., Smith, J. L., Xiong, S., & Markesbery, W. R. (2005) · Neurotoxicity Research · doi:10.1007/bf03033884 · Cited by 98
Ho, G. J., Hashimoto, M., Adame, A., Izu, M., Alford, M. F., Thal, L. J., Hansen, L. A., & Masliah, E. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.016 · Cited by 97
Self-citationSokolow, S., Luu, S. H., Nandy, K., Miller, C. A., Vinters, H. V., Poon, W. W., & Gylys, K. H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.027 · Cited by 97
Tannenberg, R. K., Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.05.004 · Cited by 96
Scheff, S. W., Sparks, D. L., & PRICE, D. A. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106884 · Cited by 95
Rose, J. B., Crews, L. A., Rockenstein, E. M., Adame, A., Mante, M., Hersh, L. B., Gage, F. H., Spencer, B. J., Potkar, R., Marr, R. A., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4220-08.2009 · Cited by 94
Self-citationQuantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease
Scheff, S. W., Sparks, D. L., & PRICE, D. A. (1993) · Annals of Neurology · doi:10.1002/ana.410340309 · Cited by 94
Fonseca, M., Soriano, E., Ferrer, I., Martínez, A., & Tun˜on, T. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90324-9 · Cited by 90
Akram, A., Christoffel, D. J., Rocher, A. B., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Herrmann, F. R., Haroutunian, V. H., Giannakopoulos, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.007 · Cited by 90
Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease
Fonseca, M., & Soriano, E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00622-w · Cited by 89
Davidsson, P., Jahn, R., Bergquist, J., Ekman, R., & Blennow, K. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815094 · Cited by 89
Weiler, R., Lassmann, H., Fischer, P., Jellinger, K., & Winkler, H. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81408-g · Cited by 88
Synaptic Density in the Inner Molecular Layer of the Hippocampal Dentate Gyrus in Alzheimer Disease
Scheff, S. W., & PRICE, D. A. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199812000-00006 · Cited by 86
Leuba, G., Walzer, C., Vernay, A., Carnal, B., Kraftsik, R., Piotton, F., Marin, P., Bouras, C., & Savioz, A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.012 · Cited by 83
Alzheimer's disease-related synapse loss in the cingulate cortex
Scheff, S. W., & PRICE, D. A. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3509 · Cited by 77
Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia
Hansen, L. A., Daniel, S. E., Wilcock, G., & Love, S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.653 · Cited by 76
Cortical Synapse Loss in progressive Supranuclear palsy
Bigio, E. H., Vono, M. B., Satumtira, S., Adamson, J. L., Sontag, E., Hynan, L. S., White, C. L., Baker, M. C., & Hutton, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.5.403 · Cited by 72
Brown, D. F., Risser, R. C., Bigio, E. H., Tripp, P., Stiegler, A., Welch, E., Eagan, K. P., Hladik, C. L., & White, C. L. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199810000-00007 · Cited by 69
Perdahl, E., Adolfsson, R., Alafuzoff, I. I., Albert, K. A., Nestler, E. J., Greengard, P., & Winblad, B. G. (1984) · Journal of Neural Transmission · doi:10.1007/bf01245030 · Cited by 67
Bogdanović, N., Davidsson, P., Volkmann, I., Winblad, B. G., & Blennow, K. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070088 · Cited by 66
Alford, M. F., Masliah, E., Hansen, L. A., & Terry, R. D. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.2.8288869 · Cited by 66
Self-citationIwakiri, M., Mizukami, K., Ikonomović, M. D., Ishikawa, M., Hidaka, S., Abrahamson, E. E., DeKosky, S. T., & Asada, T. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-0985-9 · Cited by 66
Heffernan, J. M., Eastwood, S. L., Nagy, Z., Sanders, M. W., McDonald, B., & Harrison, P. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6772 · Cited by 65
Age‐related changes in gene expression are accelerated in Alzheimer's disease
Saetre, P., JAZIN, E. E., & Emilsson, L. (2011) · Synapse · doi:10.1002/syn.20933 · Cited by 65
Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies
Mukaetova-Ladinska, E. B., Andras, A., Milne, J., Abdel‐All, Z., Borr, I., Jaros, E., Perry, R. H., Honer, W. G., Cleghorn, A., Doherty, J., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827c5710 · Cited by 64
Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease
Ferrari-Dileo, G., Mash, D. C., & Flynn, D. D. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160113 · Cited by 63
Regional alteration of synapsin I in the hippocampal formation of Alzheimer?s disease patients
Song, Q., Hu, X., Xu, H., & Zhou, J. (2004) · Acta Neuropathologica · doi:10.1007/s00401-003-0800-4 · Cited by 62
Synapse Stability in the Precuneus Early in the Progression of Alzheimer's Disease
Scheff, S. W., PRICE, D. A., Schmitt, F. A., Roberts, K. N., Ikonomović, M. D., & Mufson, E. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122353 · Cited by 61
Proctor, D. T., Coulson, E. J., & Dodd, P. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.02.002 · Cited by 60
Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain
O’Neill, C., Wiehager, B., Fowler, C. J., Ravid, R., Winblad, B. G., & Cowburn, R. F. (1994) · Brain Research · doi:10.1016/0006-8993(94)91017-0 · Cited by 59
The synaptic proteome in Alzheimer's disease
Chang, R. Y. K., Nouwens, A. S., Dodd, P. R., & Etheridge, N. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.04.009 · Cited by 55
Gertz, H., Cervós‐Navarro, J., & Ewald, V. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90720-8 · Cited by 53
Altered NCAM Expression Associated with the Cholinergic System in Alzheimer's Disease
Aisa, B., Gil-Bea, F. J., Solas, M., García-Alloza, M., Chen, C., Lai, M. K. P., Francis, P. T., & Ramírez, M. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1398 · Cited by 52
Proteomic analysis of postsynaptic density in Alzheimer's Disease
Zhou, J., Jones, D. R., Duong, D. M., Levey, A. I., Lah, J. J., & Peng, J. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.03.016 · Cited by 49
Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease.
Reid, R., Sabbagh, M., Bloom, J. C., Tiraboschi, P., & Thal, L. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00168-8 · Cited by 45
Changed Clathrin Regulatory Proteins in the Brains of Alzheimer's Disease Patients and Animal Models
Cao, Y., Xiao, Y. C., Ravid, R., & Guan, Z. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100162 · Cited by 43
Zhan, S., Beyreuther, K. T., & Schmitt, H. P. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106701 · Cited by 43
Coleman, P. D., Kazee, A. M., Lapham, L. W., Eskin, T. A., & Rogers, K. E. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90085-c · Cited by 42
Davidsson, P., Bogdanović, N., Lannfelt, L., & Blennow, K. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051266 · Cited by 40
Reduced in vitro phosphorylation of synapsin I (site 1) in Alzheimer's disease postmortem tissues.
Parks, K., Sugár, J., Haroutunian, V., Bierer, L., Perl, D. P., & Wallace, W. (1991) · Brain Research. Molecular Brain Research · doi:10.1016/0169-328x(91)90137-m · Cited by 39
Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease
Sabbagh, M. N., Reid, R. T., Corey‐Bloom, J., Rao, T. S., Hansen, L. A., Alford, M. F., Masliah, E., Adem, A., Lloyd, G. K., & Thal, L. J. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050090 · Cited by 37
Self-citationE4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer’s disease
Corey‐Bloom, J., Tiraboschi, P., Hansen, L. A., Alford, M. F., Schoos, B., Sabbagh, M. N., Masliah, E., & Thal, L. J. (2000) · Neurology · doi:10.1212/wnl.54.2.403 · Cited by 37
Self-citationSenile Dementia of the Neurofibrillary Tangle Type: A Comparison with Alzheimer’s Disease
Yamada, M., Itoh, Y., Sodeyama, N., Suematsu, N., Otomo, E., Matsushita, M., & Mizusawa, H. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051245 · Cited by 36
Differential synaptic loss in the cortex in Alzheimerʼs disease: a study using archival material
Clinton, J., Blackman, S. E.-A., Royston, M. C., & Roberts, G. W. (1994) · Neuroreport · doi:10.1097/00001756-199401120-00032 · Cited by 35
Computer-Assisted Morphometry of Synaptic Plasticity during Aging and Dementia
Bertoni–Freddari, C., Fattoretti, P., Meier‐Ruge, W., & ULRICH, J. (1989) · Pathology - Research and Practice · doi:10.1016/s0344-0338(89)80243-2 · Cited by 34
Targeting Synaptic Pathology with a Novel Affinity Mass Spectrometry Approach
Brinkmalm, A., Brinkmalm, G., Honer, W. G., Moreno, J. A., Jakobsson, J., Mallucci, G. R., Zetterberg, H., Blennow, K., & Öhrfelt, A. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.040113 · Cited by 34
Nishiyama, E., Ohwada, J., Iwamoto, N., & Arai, H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90388-2 · Cited by 30
Greene, J. R. T., Radenahmad, N., Wilcock, G. K., Neal, J., & Pearson, R. C. A. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00351.x · Cited by 29
Lippa, C. F. (2004) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750401900606 · Cited by 29
Tau Proteins in the Temporal and Frontal Cortices in Patients With Vascular Dementia
Mukaetova‐Ladinska, E. B., Abdel‐All, Z., Santiago-Mujika, E., Li, M., Craggs, L., Oakley, A. E., Honer, W. G., & Kalaria, R. N. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000157 · Cited by 28
Targeted quantitative analysis of synaptic proteins in Alzheimer’s disease brain
Chang, R. Y. K., Etheridge, N., Dodd, P. R., & Nouwens, A. S. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.05.011 · Cited by 28
Vallortigara, J., Rangarajan, S., Whitfield, D., Alghamdi, A. A., Howlett, D. R., Hortobágyi, T., Johnson, M. A., Attems, J., Ballard, C. G., Thomas, A. J., et al. (2014) · F1000Research · doi:10.12688/f1000research.3786.1 · Cited by 27
Paula-Barbosa, M. M., Saraiva, A., Tavares, M. A., Borges, M. M., & Verwer, R. W. H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb03533.x · Cited by 25
Chan‐Palay, V., Höchli, M., Savaskan, E., & Hungerecker, G. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107290 · Cited by 25
Ss, Z., Sandbrink, R., Beyreuther, K. T., et al. (1995) · PubMed · Cited by 19
Toward a unified therapeutics approach targeting putative amyloid-β oligomer receptors
Overk, C., & Masliah, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414554111 · Cited by 16
Self-citationZhan, S., Beyreuther, K. T., & Schmitt, H. P. (1993) · Acta Neuropathologica · doi:10.1007/bf00304140 · Cited by 13
Gap-43 message levels in anterior cerebellum in Alzheimer's disease
Cheetham, J., Martzen, M. R., Kazee, A. M., & Coleman, P. D. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00257-s · Cited by 10
Bigio, E. H., Reisch, J., White, C. L., Satumtira, S., Sontag, E., & Bonte, F. J. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000067970 · Cited by 2
Cited by
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
the Synaptic Health Endpoints Working Group, Colom-Cadena, M., Spires-Jones, T., Zetterberg, H., Blennow, K., Caggiano, A., DeKosky, S. T., Fillit, H., Harrison, J. E., Schneider, L. S., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00588-4 · Cited by 328
Synaptic basis of Alzheimer’s disease: Focus on synaptic amyloid beta, P-tau and mitochondria
John, A., & Reddy, P. H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101208 · Cited by 359
Alzheimer's Association Calcium Hypothesis Workgroup, & Khachaturian, Z. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.12.006 · Cited by 311
In vivo measurement of widespread synaptic loss in Alzheimer’s disease with SV2A PET
Mecca, A. P., Chen, M., O'Dell, R. S., Naganawa, M., Toyonaga, T., Godek, T. A., Harris, J. E., Bartlett, H. H., Zhao, W., Nabulsi, N. B., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12097 · Cited by 288
Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease
Otero-Garcia, M., Mahajani, S. U., Wakhloo, D., Tang, W., Xue, Y.-Q., Morabito, S., Pan, J., Oberhauser, J., Madira, A. E., Shakouri, T., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.021 · Cited by 262
Metadata
- Authors
- de Wilde, M. C., Overk, C. R., Sijben, J. W., & Masliah, E.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-01-14
- Volume
- 12
- Issue
- 6
- Pages
- 633-644
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2271127896
- Cited by
- 278
- References
- 136
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.